Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
32
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Bjorkquist Jeanette M | Principal Accounting Officer | 21 | $0 | $14.9K | 2026-06-17 |
| Houghton Michael | Director | 7 | $50.0K | $0 | 2026-06-04 |
| Johnson-Pratt Lisa | Director | 6 | $0 | $0 | 2026-06-04 |
| McHutchison John G | Director | 24 | $0 | $439.0K | 2026-06-04 |
| Consylman Gina | Director | 7 | $0 | $0 | 2026-06-04 |
| Mahony Susan | Director | 9 | $0 | $0 | 2026-06-04 |
| ALTIG ANTHONY E | Director | 14 | $0 | $0 | 2026-06-04 |
| GILEAD SCIENCES, INC. | 10% Owner | 7 | $20.10M | $0 | 2026-05-26 |
| White Nicole S | Chief Manufacturing Officer | 17 | $0 | $44.3K | 2026-03-30 |
| Gaggar Anuj | Chief Medical Officer | 4 | $0 | $0 | 2026-03-29 |
| Delaney William E IV | Chief Scientific Officer | 26 | $0 | $52.4K | 2026-03-29 |
| Okazaki Jason A | President & COO | 32 | $0 | $101.2K | 2026-03-29 |
| RINGO WILLIAM R | Director | 50 | $0 | $510.4K | 2025-06-05 |
| Schornstein Alexander | 10% Owner | 10 | $1.42M | $0 | 2024-11-25 |
| Samar Michael P. | SVP, Finance and Bus. Ops, PAO | 8 | $0 | $9.4K | 2022-07-25 |
| DiMarchi Richard D | Director | 9 | $0 | $0 | 2022-05-25 |
| Stamm Luisa M | Chief Medical Officer | 9 | $0 | $24.7K | 2022-03-30 |
| HOLUBIAK MYRON Z | Director | 9 | $0 | $0 | 2021-05-20 |
| Russo Thomas Joseph | CFO | 4 | $0 | $0 | 2021-03-29 |
| Papkoff Jacqueline Sybil | See remarks | 11 | $0 | $56.5K | 2020-12-14 |
| Kim Helen Susan | Director | 4 | $0 | $0 | 2020-06-11 |
| LEWIS ALAN | Director | 6 | $0 | $0 | 2020-06-11 |
| Colonno Richard James | See Remarks | 16 | $0 | $944.0K | 2020-03-31 |
| Small Derek A | Director | 10 | $154.8K | $0 | 2020-01-02 |
| AUERBACH MARK | Director | 7 | $0 | $0 | 2019-05-17 |
| Lopatin Uri A | Chief Medical Officer | 8 | $0 | $623.0K | 2019-03-29 |
| COOPER GRAHAM K | See Remarks | 4 | $0 | $0 | 2019-03-29 |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | 2 | $9.3K | $0 | 2018-04-17 |
| Rollins Thomas E | See Remarks | 5 | $0 | $0 | 2018-03-29 |
| BARRETT DAVID JONATHAN | See Remarks | 4 | $0 | $0 | 2017-03-29 |
| ELLISON RUSSELL H | Director | 3 | $0 | $0 | 2014-07-11 |
| Zlotnick Adam | 10% Owner | 1 | $0 | $0 | 2014-07-10 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Bjorkquist Jeanette M | PFO and PAO | S Sale | 2026-06-17 | 2026-06-18 | 29 | $23.25 | $674 | 14,560 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Consylman Gina | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Houghton Michael | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Johnson-Pratt Lisa | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Mahony Susan | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| McHutchison John G | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| GILEAD SCIENCES, INC. | 10% Owner | A Award | 2026-05-26 | 2026-05-27 | 471,698 | $26.50 | $12.50M | 4,977,089 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2026-03-30 | 2026-03-31 | 188 | $26.65 | $5.0K | 37,486 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2026-03-30 | 2026-03-31 | 9 | $27.49 | $247 | 37,477 | SEC↗ |
| Bjorkquist Jeanette M | PFO and PAO | S Sale | 2026-03-30 | 2026-03-31 | 312 | $26.65 | $8.3K | 11,105 | SEC↗ |
| Bjorkquist Jeanette M | PFO and PAO | S Sale | 2026-03-30 | 2026-03-31 | 16 | $27.49 | $440 | 11,089 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award | 2026-03-29 | 2026-06-05 | 50,750 | — | $0 | 163,354 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award | 2026-03-29 | 2026-06-05 | 14,000 | — | $0 | 60,330 | SEC↗ |
| Bjorkquist Jeanette M | PFO and PAO | A Award | 2026-03-29 | 2026-06-05 | 3,500 | — | $0 | 14,589 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | A Award | 2026-03-29 | 2026-06-05 | 14,000 | — | $0 | 48,145 | SEC↗ |
| Gaggar Anuj | Chief Medical Officer | A Award | 2026-03-29 | 2026-06-05 | 14,000 | — | $0 | 42,688 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award | 2026-03-29 | 2026-03-31 | 94,250 | — | $0 | 111,916 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award | 2026-03-29 | 2026-03-31 | 26,000 | — | $0 | 45,642 | SEC↗ |
| Gaggar Anuj | Chief Medical Officer | A Award | 2026-03-29 | 2026-03-31 | 26,000 | — | $0 | 28,000 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | A Award | 2026-03-29 | 2026-03-31 | 26,000 | — | $0 | 37,674 | SEC↗ |
| Bjorkquist Jeanette M | PFO and PAO | A Award | 2026-03-29 | 2026-03-31 | 6,500 | — | $0 | 11,417 | SEC↗ |
| GILEAD SCIENCES, INC. | 10% Owner | P Buy deriv | 2025-08-08 | 2025-10-03 | 1,147,960 | — | $0 | 1,147,960 | SEC↗ |
| GILEAD SCIENCES, INC. | 10% Owner | P Buy deriv | 2025-08-08 | 2025-10-03 | 1,147,960 | — | $0 | 1,147,960 | SEC↗ |
| GILEAD SCIENCES, INC. | 10% Owner | P Buy | 2025-08-08 | 2025-10-03 | 2,295,920 | — | $0 | 4,505,391 | SEC↗ |
| Bjorkquist Jeanette M | PFO and PAO | A Award deriv | 2025-06-16 | 2025-06-17 | 600 | — | $0 | 600 | SEC↗ |
| Bjorkquist Jeanette M | PFO and PAO | A Award | 2025-06-16 | 2025-06-17 | 300 | — | $0 | 5,097 | SEC↗ |
| Consylman Gina | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 3,500 | — | $0 | 3,500 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 3,500 | — | $0 | 3,500 | SEC↗ |
| RINGO WILLIAM R | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 3,500 | — | $0 | 3,500 | SEC↗ |
| Johnson-Pratt Lisa | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 3,500 | — | $0 | 3,500 | SEC↗ |
| McHutchison John G | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 3,500 | — | $0 | 3,500 | SEC↗ |
| Mahony Susan | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 3,500 | — | $0 | 3,500 | SEC↗ |
| Houghton Michael | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 3,500 | — | $0 | 3,500 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2025-03-31 | 2025-04-01 | 197 | $9.85 | $1.9K | 11,674 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2025-03-31 | 2025-04-01 | 355 | $9.85 | $3.5K | 14,757 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | S Sale | 2025-03-31 | 2025-04-01 | 180 | $9.85 | $1.8K | 4,617 | SEC↗ |
| McHutchison John G | Director | S Sale | 2025-03-31 | 2025-04-15 | 757 | $9.85 | $7.5K | 18,347 | SEC↗ |
| Gaggar Anuj | Chief Medical Officer | A Award deriv | 2025-03-29 | 2025-04-01 | 24,200 | — | $0 | 24,200 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | A Award deriv | 2025-03-29 | 2025-04-01 | 20,400 | — | $0 | 20,400 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award deriv | 2025-03-29 | 2025-04-01 | 71,100 | — | $0 | 71,100 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | A Award deriv | 2025-03-29 | 2025-04-01 | 1,900 | — | $0 | 1,900 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award deriv | 2025-03-29 | 2025-04-01 | 25,500 | — | $0 | 25,500 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | A Award | 2025-03-29 | 2025-04-01 | 1,655 | — | $0 | 4,797 | SEC↗ |
| Houghton Michael | Director | P Buy | 2024-12-30 | 2024-12-31 | 3,202 | $15.61 | $50.0K | 3,202 | SEC↗ |
| GILEAD SCIENCES, INC. | 10% Owner | P Buy | 2024-12-19 | 2024-12-23 | 940,499 | $21.37 | $20.10M | 2,209,471 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2024-11-25 | 2024-11-26 | 5,000 | $14.85 | $74.3K | 728,113 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2024-11-25 | 2024-11-26 | 2,976 | $15.00 | $44.6K | 723,113 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2024-11-22 | 2024-11-26 | 17,024 | $14.87 | $253.1K | 720,137 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2024-11-18 | 2024-11-19 | 40 | $16.29 | $652 | 11,871 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2024-10-08 | 2024-10-09 | 10,000 | $14.58 | $145.8K | 703,113 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2024-10-03 | 2024-10-04 | 197 | $14.81 | $2.9K | 14,904 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2024-10-03 | 2024-10-04 | 157 | $14.81 | $2.3K | 11,911 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2024-08-02 | 2024-08-05 | 981 | $14.23 | $14.0K | 15,101 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2024-08-02 | 2024-08-05 | 785 | $14.23 | $11.2K | 12,068 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2024-07-05 | 2024-07-08 | 4,438 | $12.52 | $55.6K | 693,113 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2024-07-03 | 2024-07-08 | 4,562 | $12.29 | $56.1K | 688,675 | SEC↗ |
| GILEAD SCIENCES, INC. | 10% Owner | P Buy deriv | 2024-06-17 | 2024-06-20 | 179,500 | — | $0 | 179,500 | SEC↗ |
| GILEAD SCIENCES, INC. | 10% Owner | P Buy | 2024-06-17 | 2024-06-20 | 179,500 | — | $0 | 1,268,972 | SEC↗ |
| RINGO WILLIAM R | Director | A Award deriv | 2024-05-29 | 2024-05-30 | 2,750 | — | $0 | 2,750 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award deriv | 2024-05-29 | 2024-05-30 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Houghton Michael | Director | A Award deriv | 2024-05-29 | 2024-05-30 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Consylman Gina | Director | A Award deriv | 2024-05-29 | 2024-05-30 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Mahony Susan | Director | A Award deriv | 2024-05-29 | 2024-05-30 | 2,750 | — | $0 | 2,750 | SEC↗ |
| McHutchison John G | Director | A Award deriv | 2024-05-29 | 2024-05-30 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Johnson-Pratt Lisa | Director | A Award deriv | 2024-05-29 | 2024-05-30 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2024-05-23 | 2024-05-24 | 549 | $14.93 | $8.2K | 16,082 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2024-05-23 | 2024-05-24 | 172 | $14.93 | $2.6K | 12,853 | SEC↗ |
| McHutchison John G | Director | S Sale | 2024-05-23 | 2024-05-24 | 2,117 | $14.93 | $31.6K | 19,104 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | S Sale | 2024-05-23 | 2024-05-24 | 24 | $14.93 | $358 | 3,142 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2024-04-30 | 2024-05-01 | 1,569 | $12.71 | $19.9K | 16,423 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2024-04-30 | 2024-05-01 | 1,255 | $12.71 | $16.0K | 13,025 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award | 2024-04-29 | 2024-05-01 | 3,333 | — | $0 | 16,109 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award | 2024-04-29 | 2024-05-01 | 4,166 | — | $0 | 17,992 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | A Award | 2024-04-29 | 2024-05-01 | 3,333 | — | $0 | 14,280 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2024-04-01 | 2024-04-02 | 354 | $13.07 | $4.6K | 13,826 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2024-04-01 | 2024-04-02 | 197 | $13.07 | $2.6K | 10,947 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | S Sale | 2024-04-01 | 2024-04-02 | 114 | $13.07 | $1.5K | 3,166 | SEC↗ |
| McHutchison John G | Director | S Sale | 2024-04-01 | 2024-04-02 | 1,206 | $13.07 | $15.8K | 21,221 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award deriv | 2024-03-29 | 2024-04-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award deriv | 2024-03-29 | 2024-04-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | A Award deriv | 2024-03-29 | 2024-04-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | A Award deriv | 2024-03-29 | 2024-04-02 | 1,550 | — | $0 | 1,550 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | A Award | 2024-03-29 | 2024-04-02 | 850 | — | $0 | 3,280 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2024-03-27 | 2024-03-29 | 392 | $12.87 | $5.0K | 14,180 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2024-01-18 | 2024-01-19 | 345,086 | $0.80 | $276.1K | 8,209,372 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2024-01-17 | 2024-01-19 | 299,994 | $0.78 | $234.0K | 7,864,286 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2023-11-21 | 2023-11-22 | 100,000 | $0.67 | $67.0K | 7,564,292 | SEC↗ |
| Schornstein Alexander | 10% Owner | P Buy | 2023-11-20 | 2023-11-22 | 300,000 | $0.72 | $216.0K | 7,464,292 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2023-11-17 | 2023-11-21 | 477 | $0.69 | $329 | 93,774 | SEC↗ |
| Gaggar Anuj | Chief Medical Officer | A Award deriv | 2023-11-08 | 2023-11-13 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2023-10-03 | 2023-10-04 | 2,363 | $0.80 | $1.9K | 174,923 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | S Sale | 2023-10-03 | 2023-10-04 | 1,891 | $0.80 | $1.5K | 150,853 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | S Sale | 2023-10-03 | 2023-10-04 | 1,891 | $0.80 | $1.5K | 94,251 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award | 2023-10-02 | 2023-10-04 | 12,500 | — | $0 | 177,286 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award | 2023-10-02 | 2023-10-04 | 10,000 | — | $0 | 152,744 | SEC↗ |
| White Nicole S | Chief Manufacturing Officer | A Award | 2023-10-02 | 2023-10-04 | 10,000 | — | $0 | 96,142 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2023-08-02 | 2023-08-03 | 11,827 | $1.09 | $12.9K | 164,786 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | S Sale | 2023-08-02 | 2023-08-03 | 9,461 | $1.09 | $10.3K | 142,744 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | S Sale | 2023-07-24 | 2023-07-25 | 844 | $1.07 | $903 | 26,688 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award | 2023-06-22 | 2023-06-23 | 50,000 | — | $0 | 176,613 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award | 2023-06-22 | 2023-06-23 | 40,000 | — | $0 | 152,205 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | S Sale | 2023-05-30 | 2023-05-31 | 4,232 | $0.96 | $4.1K | 112,205 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Consylman Gina | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Houghton Michael | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Johnson-Pratt Lisa | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Mahony Susan | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McHutchison John G | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RINGO WILLIAM R | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2023-05-23 | 2023-05-24 | 6,561 | $1.04 | $6.8K | 126,613 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | S Sale | 2023-05-23 | 2023-05-24 | 6,561 | $1.04 | $6.8K | 116,437 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | S Sale | 2023-05-23 | 2023-05-24 | 274 | $1.04 | $285 | 27,532 | SEC↗ |
| McHutchison John G | Director | S Sale | 2023-05-23 | 2023-05-24 | 25,972 | $1.04 | $27.0K | 169,160 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award | 2023-05-22 | 2023-05-24 | 35,000 | — | $0 | 133,174 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award | 2023-05-22 | 2023-05-24 | 35,000 | — | $0 | 122,998 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | A Award | 2023-05-22 | 2023-05-24 | 1,500 | — | $0 | 27,806 | SEC↗ |
| McHutchison John G | Director | A Award | 2023-05-22 | 2023-05-24 | 117,500 | — | $0 | 295,132 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2023-03-30 | 2023-03-31 | 4,247 | $0.82 | $3.5K | 98,174 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | S Sale | 2023-03-30 | 2023-03-31 | 3,421 | $0.82 | $2.8K | 85,498 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | S Sale | 2023-03-30 | 2023-03-31 | 774 | $0.82 | $635 | 23,806 | SEC↗ |
| McHutchison John G | Director | S Sale | 2023-03-30 | 2023-03-31 | 14,883 | $0.82 | $12.2K | 177,632 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award deriv | 2023-03-29 | 2023-03-31 | 470,000 | — | $0 | 470,000 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award deriv | 2023-03-29 | 2023-03-31 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | A Award deriv | 2023-03-29 | 2023-03-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | A Award | 2023-03-29 | 2023-03-31 | 6,250 | — | $0 | 24,580 | SEC↗ |
| Okazaki Jason A | CEO and President | S Sale | 2023-03-27 | 2023-03-28 | 4,693 | $1.02 | $4.8K | 102,421 | SEC↗ |
| Bjorkquist Jeanette M | Principal Accounting Officer | A Award deriv | 2023-02-16 | 2023-03-31 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Okazaki Jason A | CEO and President | A Award | 2023-02-16 | 2023-02-17 | 12,500 | — | $0 | 107,114 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award | 2023-02-16 | 2023-02-17 | 10,000 | — | $0 | 88,919 | SEC↗ |
| McHutchison John G | Chief Executive Officer | S Sale | 2022-08-08 | 2022-08-10 | 12,314 | $2.13 | $26.2K | 192,515 | SEC↗ |
| Okazaki Jason A | President & COO | A Award deriv | 2022-08-01 | 2022-08-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award deriv | 2022-08-01 | 2022-08-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Samar Michael P. | Chief Financial Officer | S Sale | 2022-07-25 | 2022-07-26 | 2,020 | $2.22 | $4.5K | 77,228 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | S Sale | 2022-05-31 | 2022-06-02 | 4,164 | $1.92 | $8.0K | 76,419 | SEC↗ |
| RINGO WILLIAM R | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Consylman Gina | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DiMarchi Richard D | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Houghton Michael | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Johnson-Pratt Lisa | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Mahony Susan | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McHutchison John G | CEO and President | S Sale | 2022-03-30 | 2022-03-31 | 4,614 | $2.17 | $10.0K | 204,829 | SEC↗ |
| Okazaki Jason A | Chief Operating Officer | S Sale | 2022-03-30 | 2022-03-31 | 1,269 | $2.17 | $2.8K | 94,614 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | S Sale | 2022-03-30 | 2022-03-31 | 1,038 | $2.17 | $2.3K | 78,083 | SEC↗ |
| Stamm Luisa M | Chief Medical Officer | S Sale | 2022-03-30 | 2022-03-31 | 1,038 | $2.17 | $2.3K | 40,315 | SEC↗ |
| Samar Michael P. | Chief Financial Officer | S Sale | 2022-03-30 | 2022-03-31 | 2,285 | $2.17 | $5.0K | 76,748 | SEC↗ |
| McHutchison John G | CEO and President | A Award deriv | 2022-03-29 | 2022-03-31 | 83,750 | — | $0 | 83,750 | SEC↗ |
| McHutchison John G | CEO and President | A Award deriv | 2022-03-29 | 2022-03-31 | 335,000 | — | $0 | 335,000 | SEC↗ |
| Okazaki Jason A | Chief Operating Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Okazaki Jason A | Chief Operating Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Stamm Luisa M | Chief Medical Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Stamm Luisa M | Chief Medical Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Samar Michael P. | Chief Financial Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 26,250 | — | $0 | 26,250 | SEC↗ |
| Samar Michael P. | Chief Financial Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 105,000 | — | $0 | 105,000 | SEC↗ |
| McHutchison John G | CEO and President | A Award | 2022-03-29 | 2022-03-31 | 83,750 | — | $0 | 209,443 | SEC↗ |
| Okazaki Jason A | Chief Operating Officer | A Award | 2022-03-29 | 2022-03-31 | 31,250 | — | $0 | 95,883 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award | 2022-03-29 | 2022-03-31 | 25,000 | — | $0 | 79,121 | SEC↗ |
| Stamm Luisa M | Chief Medical Officer | A Award | 2022-03-29 | 2022-03-31 | 22,500 | — | $0 | 41,353 | SEC↗ |
| Samar Michael P. | Chief Financial Officer | A Award | 2022-03-29 | 2022-03-31 | 26,250 | — | $0 | 79,033 | SEC↗ |
| Okazaki Jason A | Chief Operating Officer | S Sale | 2022-03-28 | 2022-03-29 | 4,617 | $2.24 | $10.3K | 64,633 | SEC↗ |
| McHutchison John G | CEO and President | S Sale | 2021-08-09 | 2021-08-10 | 12,156 | $3.60 | $43.8K | 125,693 | SEC↗ |
| Samar Michael P. | SVP, Fin. & Bus. Ops, PFO, P | A Award | 2021-07-22 | 2021-07-22 | 10,938 | — | $0 | 51,783 | SEC↗ |
| Houghton Michael | Director | A Award deriv | 2021-07-19 | 2021-07-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | S Sale | 2021-05-27 | 2021-06-01 | 4,129 | $4.03 | $16.6K | 53,121 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Consylman Gina | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DiMarchi Richard D | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOLUBIAK MYRON Z | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Johnson-Pratt Lisa | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Mahony Susan | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RINGO WILLIAM R | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| McHutchison John G | CEO and President | A Award deriv | 2021-03-29 | 2021-04-02 | 305,000 | — | $0 | 305,000 | SEC↗ |
| Okazaki Jason A | Chief Legal & Business Offic | A Award deriv | 2021-03-29 | 2021-04-02 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Russo Thomas Joseph | CFO | A Award deriv | 2021-03-29 | 2021-04-02 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Stamm Luisa M | Chief Medical Officer | A Award deriv | 2021-03-29 | 2021-04-02 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award deriv | 2021-03-29 | 2021-04-02 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Okazaki Jason A | Chief Legal & Business Offic | A Award | 2021-03-29 | 2021-04-02 | 13,750 | — | $0 | 67,250 | SEC↗ |
| Russo Thomas Joseph | CFO | A Award | 2021-03-29 | 2021-04-02 | 11,250 | — | $0 | 54,633 | SEC↗ |
| Stamm Luisa M | Chief Medical Officer | A Award | 2021-03-29 | 2021-04-02 | 11,250 | — | $0 | 18,853 | SEC↗ |
| Delaney William E IV | Chief Scientific Officer | A Award | 2021-03-29 | 2021-04-02 | 11,250 | — | $0 | 56,250 | SEC↗ |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | S Sale | 2020-12-14 | 2020-12-15 | 1,297 | $6.15 | $8.0K | 37,364 | SEC↗ |
| Stamm Luisa M | Chief Medical Officer | S Sale | 2020-11-09 | 2020-11-10 | 4,397 | $5.10 | $22.4K | 7,603 | SEC↗ |
| Consylman Gina | Director | A Award deriv | 2020-10-19 | 2020-10-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McHutchison John G | CEO and President | S Sale | 2020-08-07 | 2020-08-10 | 756 | $22.50 | $17.0K | 137,849 | SEC↗ |
| McHutchison John G | CEO and President | S Sale | 2020-08-07 | 2020-08-10 | 11,395 | $21.76 | $248.0K | 138,605 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DiMarchi Richard D | Director | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HOLUBIAK MYRON Z | Director | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kim Helen Susan | Director | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LEWIS ALAN | Director | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Mahony Susan | Director | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RINGO WILLIAM R | Director | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Delaney William E IV | CSO, Virology | A Award deriv | 2020-05-27 | 2020-05-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Delaney William E IV | CSO, Virology | A Award | 2020-05-27 | 2020-05-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Colonno Richard James | EVP & CSO, Virology Ops | S Sale | 2020-03-31 | 2020-03-31 | 7,812 | $15.04 | $117.5K | 137,009 | SEC↗ |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | S Sale | 2020-03-30 | 2020-03-31 | 1,254 | $14.22 | $17.8K | 38,661 | SEC↗ |
| McHutchison John G | CEO and President | A Award deriv | 2020-03-27 | 2020-03-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Colonno Richard James | EVP & CSO, Virology Ops | A Award deriv | 2020-03-27 | 2020-03-31 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | A Award deriv | 2020-03-27 | 2020-03-31 | 34,000 | — | $0 | 34,000 | SEC↗ |
| McHutchison John G | CEO and President | A Award | 2020-03-27 | 2020-03-31 | 50,000 | — | $0 | 150,000 | SEC↗ |
| Russo Thomas Joseph | CFO | A Award | 2020-03-27 | 2020-03-31 | 43,383 | — | $0 | 43,383 | SEC↗ |
| Colonno Richard James | EVP & CSO, Virology Ops | A Award | 2020-03-27 | 2020-03-31 | 17,000 | — | $0 | 144,821 | SEC↗ |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | A Award | 2020-03-27 | 2020-03-31 | 17,000 | — | $0 | 39,915 | SEC↗ |
| Okazaki Jason A | Chief Legal & Business Offic | A Award deriv | 2020-03-26 | 2020-03-30 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Okazaki Jason A | Chief Legal & Business Offic | A Award | 2020-03-26 | 2020-03-30 | 50,000 | — | $0 | 52,500 | SEC↗ |
| RINGO WILLIAM R | Director | G Gift | 2020-02-28 | 2020-06-15 | 2,000 | — | $0 | 17,465 | SEC↗ |
| Small Derek A | Director | A Award | 2020-01-02 | 2020-01-03 | 125,000 | — | $0 | 828,791 | SEC↗ |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | S Sale | 2019-12-13 | 2019-12-16 | 1,460 | $21.00 | $30.7K | 22,915 | SEC↗ |
| Colonno Richard James | EVP & CSO, Virology Ops | M Exercise deriv | 2019-12-12 | 2019-12-16 | 33,061 | — | $0 | 166,939 | SEC↗ |
| Colonno Richard James | EVP & CSO, Virology Ops | M Exercise | 2019-12-12 | 2019-12-16 | 33,061 | $7.03 | $232.4K | 160,882 | SEC↗ |
| Colonno Richard James | EVP & CSO, Virology Ops | S Sale | 2019-12-12 | 2019-12-16 | 33,061 | $25.00 | $826.5K | 127,821 | SEC↗ |
| Stamm Luisa M | Chief Medical Officer | A Award deriv | 2019-11-06 | 2019-11-07 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Stamm Luisa M | Chief Medical Officer | A Award | 2019-11-06 | 2019-11-07 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Russo Thomas Joseph | CFO | A Award deriv | 2019-10-28 | 2019-10-28 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | A Award deriv | 2019-10-01 | 2019-10-01 | 27,500 | — | $0 | 27,500 | SEC↗ |
| Samar Michael P. | SVP, Finance and Bus. Ops, P | A Award deriv | 2019-10-01 | 2019-10-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Samar Michael P. | SVP, Finance and Bus. Ops, P | A Award | 2019-10-01 | 2019-10-01 | 2,500 | — | $0 | 20,327 | SEC↗ |
| McHutchison John G | CEO and President | A Award deriv | 2019-09-28 | 2019-10-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| McHutchison John G | CEO and President | A Award deriv | 2019-08-06 | 2019-08-08 | 500,000 | — | $0 | 500,000 | SEC↗ |
| McHutchison John G | CEO and President | A Award | 2019-08-06 | 2019-08-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AUERBACH MARK | Director | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DiMarchi Richard D | Director | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HOLUBIAK MYRON Z | Director | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kim Helen Susan | Director | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LEWIS ALAN | Director | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Mahony Susan | Director | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RINGO WILLIAM R | Director | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Small Derek A | CEO and President | A Award deriv | 2019-03-29 | 2019-04-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| COOPER GRAHAM K | See Remarks | A Award deriv | 2019-03-29 | 2019-04-02 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Colonno Richard James | See Remarks | A Award deriv | 2019-03-29 | 2019-04-02 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Lopatin Uri A | Chief Medical Officer | A Award deriv | 2019-03-29 | 2019-04-02 | 27,500 | — | $0 | 27,500 | SEC↗ |
| Papkoff Jacqueline Sybil | See Remarks | A Award deriv | 2019-03-29 | 2019-04-02 | 27,500 | — | $0 | 27,500 | SEC↗ |
| Small Derek A | CEO and President | A Award | 2019-03-29 | 2019-04-02 | 32,500 | — | $0 | 701,791 | SEC↗ |
| COOPER GRAHAM K | See Remarks | A Award | 2019-03-29 | 2019-04-02 | 17,500 | — | $0 | 117,500 | SEC↗ |
| Colonno Richard James | See Remarks | A Award | 2019-03-29 | 2019-04-02 | 16,250 | — | $0 | 126,250 | SEC↗ |
| Lopatin Uri A | Chief Medical Officer | A Award | 2019-03-29 | 2019-04-02 | 13,750 | — | $0 | 627,361 | SEC↗ |
| Papkoff Jacqueline Sybil | See Remarks | A Award | 2019-03-29 | 2019-04-02 | 13,750 | — | $0 | 24,375 | SEC↗ |
| Papkoff Jacqueline Sybil | See Remarks | A Award deriv | 2018-12-12 | 2018-12-14 | 21,250 | — | $0 | 21,250 | SEC↗ |
| COOPER GRAHAM K | See Remarks | A Award | 2018-12-12 | 2018-12-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Colonno Richard James | See Remarks | A Award | 2018-12-12 | 2018-12-14 | 20,000 | — | $0 | 110,000 | SEC↗ |
| Papkoff Jacqueline Sybil | See Remarks | A Award | 2018-12-12 | 2018-12-14 | 10,625 | — | $0 | 10,625 | SEC↗ |
| Colonno Richard James | See Remarks | A Award | 2018-11-23 | 2018-11-26 | 25,000 | — | $0 | 90,000 | SEC↗ |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev | S Sale | 2018-09-06 | 2018-09-07 | 336 | $40.01 | $13.4K | 613,611 | SEC↗ |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev | S Sale | 2018-09-05 | 2018-09-07 | 15,204 | $40.09 | $609.5K | 613,947 | SEC↗ |
| Colonno Richard James | See Remarks | A Award | 2018-07-20 | 2018-07-20 | 25,000 | — | $0 | 65,000 | SEC↗ |
| Small Derek A | CEO and President | P Buy | 2018-07-19 | 2018-07-20 | 1,200 | $41.77 | $50.1K | 669,291 | SEC↗ |
| Small Derek A | CEO and President | P Buy | 2018-07-19 | 2018-07-20 | 1,200 | $41.19 | $49.4K | 668,091 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise deriv | 2018-07-02 | 2018-07-03 | 1,000 | — | $0 | 49,000 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise | 2018-07-02 | 2018-07-03 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| RINGO WILLIAM R | Director | S Sale | 2018-07-02 | 2018-07-03 | 1,000 | $38.50 | $38.5K | 19,465 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise deriv | 2018-06-01 | 2018-06-01 | 1,000 | — | $0 | 50,000 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise | 2018-06-01 | 2018-06-01 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| RINGO WILLIAM R | Director | S Sale | 2018-06-01 | 2018-06-01 | 1,000 | $42.47 | $42.5K | 19,465 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Mahony Susan | Director | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Kim Helen Susan | Director | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| LEWIS ALAN | Director | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| HOLUBIAK MYRON Z | Director | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AUERBACH MARK | Director | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| DiMarchi Richard D | Director | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RINGO WILLIAM R | Director | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise deriv | 2018-05-01 | 2018-05-02 | 1,000 | — | $0 | 51,000 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise | 2018-05-01 | 2018-05-02 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| RINGO WILLIAM R | Director | S Sale | 2018-05-01 | 2018-05-02 | 1,000 | $43.06 | $43.1K | 19,465 | SEC↗ |
| EcoR1 Capital Fund Qualified, | 10% Owner | P Buy deriv | 2018-04-17 | 2018-04-18 | 246 | $8.50 | $2.1K | 1,213 | SEC↗ |
| EcoR1 Capital Fund Qualified, | 10% Owner | P Buy deriv | 2018-04-13 | 2018-04-17 | 967 | $7.47 | $7.2K | 967 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise deriv | 2018-04-02 | 2018-04-02 | 1,000 | — | $0 | 52,000 | SEC↗ |
| Papkoff Jacqueline Sybil | See remarks | A Award deriv | 2018-04-02 | 2018-04-02 | 106,200 | — | $0 | 106,200 | SEC↗ |
| RINGO WILLIAM R | Director | S Sale | 2018-04-02 | 2018-04-02 | 1,000 | $49.32 | $49.3K | 19,465 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise | 2018-04-02 | 2018-04-02 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| Small Derek A | CEO and President | A Award deriv | 2018-03-29 | 2018-03-30 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Colonno Richard James | See Remarks | A Award deriv | 2018-03-29 | 2018-03-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev | A Award deriv | 2018-03-29 | 2018-03-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Rollins Thomas E | Chief Development Officer | A Award deriv | 2018-03-29 | 2018-03-30 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Small Derek A | CEO and President | A Award | 2018-03-29 | 2018-03-30 | 32,500 | — | $0 | 666,891 | SEC↗ |
| Colonno Richard James | See Remarks | A Award | 2018-03-29 | 2018-03-30 | 15,000 | — | $0 | 40,000 | SEC↗ |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev | A Award | 2018-03-29 | 2018-03-30 | 7,500 | — | $0 | 629,151 | SEC↗ |
| Rollins Thomas E | Chief Development Officer | A Award | 2018-03-29 | 2018-03-30 | 3,750 | — | $0 | 3,750 | SEC↗ |
| COOPER GRAHAM K | See Remarks | A Award deriv | 2018-03-08 | 2018-03-12 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Kim Helen Susan | Director | A Award deriv | 2018-03-08 | 2018-03-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise deriv | 2018-03-01 | 2018-03-02 | 1,000 | — | $0 | 53,000 | SEC↗ |
| RINGO WILLIAM R | Director | S Sale | 2018-03-01 | 2018-03-02 | 1,000 | $56.37 | $56.4K | 19,465 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise | 2018-03-01 | 2018-03-02 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise deriv | 2018-02-01 | 2018-02-02 | 1,000 | — | $0 | 54,000 | SEC↗ |
| RINGO WILLIAM R | Director | S Sale | 2018-02-01 | 2018-02-02 | 1,000 | $46.86 | $46.9K | 19,465 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise | 2018-02-01 | 2018-02-02 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise deriv | 2018-01-02 | 2018-01-03 | 1,000 | — | $0 | 55,000 | SEC↗ |
| RINGO WILLIAM R | Director | S Sale | 2018-01-02 | 2018-01-03 | 1,000 | $45.04 | $45.0K | 19,465 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise | 2018-01-02 | 2018-01-03 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| Colonno Richard James | See Remarks | A Award | 2018-01-01 | 2018-01-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise deriv | 2017-12-01 | 2017-12-04 | 1,000 | — | $0 | 56,000 | SEC↗ |
| RINGO WILLIAM R | Director | S Sale | 2017-12-01 | 2017-12-04 | 1,000 | $49.37 | $49.4K | 19,465 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise | 2017-12-01 | 2017-12-04 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise deriv | 2017-11-01 | 2017-11-03 | 1,000 | — | $0 | 57,000 | SEC↗ |
| RINGO WILLIAM R | Director | M Exercise | 2017-11-01 | 2017-11-03 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| RINGO WILLIAM R | Director | S Sale | 2017-11-01 | 2017-11-03 | 1,000 | $29.55 | $29.6K | 19,465 | SEC↗ |